Literature DB >> 7740813

Hepatic resection for noncolorectal nonneuroendocrine metastases.

S I Schwartz1.   

Abstract

The experience with hepatic resection for metastatic lesions, exclusive of colorectal and neuroendocrine tumors, is anecdotal. The reduction in operative mortality leads to a reconsideration of the subject. A review of the literature suggests a selective approach. There is little improvement to be anticipated for resection of metastases from tumors of the esophagus, stomach, small intestine, or pancreas. Resection of metastases from primary renal cell carcinoma, Wilms' tumor, and adrenocortical carcinoma is indicated. There is little to recommend resection of metastases from gynecologic or breast primary carcinomas. Resection as palliation is to be considered for all lesions, particularly bulky metastases from ocular melanomas.

Entities:  

Mesh:

Year:  1995        PMID: 7740813     DOI: 10.1007/BF00316982

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  14 in total

1.  Five-year survival after hepatic lobectomy for metastatic hypernephroma.

Authors:  F H STRAUS; E F SCANLON
Journal:  AMA Arch Surg       Date:  1956-02

2.  Hepatic resection in 128 patients: a 24-year experience.

Authors:  M E Sesto; D P Vogt; R E Hermann
Journal:  Surgery       Date:  1987-11       Impact factor: 3.982

3.  Factors influencing survival in patients with untreated hepatic metastases.

Authors:  B M Jaffe; W L Donegan; F Watson; J S Spratt
Journal:  Surg Gynecol Obstet       Date:  1968-07

4.  A ten year experience with hepatic resection.

Authors:  J E Tomás-de la Vega; E J Donahue; A Doolas; D L Roseman; A Straus; P D Bonomi; S G Economou
Journal:  Surg Gynecol Obstet       Date:  1984-09

Review 5.  Liver Metastases.

Authors:  J H Foster; J Lundy
Journal:  Curr Probl Surg       Date:  1981-03       Impact factor: 1.909

6.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.

Authors:  K S Hughes; R Simon; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

7.  Hepatic resection for metastatic cancer.

Authors:  W J Kortz; W C Meyers; J B Hanks; B D Schirmer; R S Jones
Journal:  Ann Surg       Date:  1984-02       Impact factor: 12.969

8.  Hepatic resection for secondary neoplasms.

Authors:  C E Morrow; T B Grage; D E Sutherland; J S Najarian
Journal:  Surgery       Date:  1982-10       Impact factor: 3.982

9.  Experience with 150 liver resections.

Authors:  S Iwatsuki; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

10.  Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients.

Authors:  J S Stehlin; P D de Ipolyi; P J Greeff; C J McGaff; B R Davis; L McNary
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

View more
  11 in total

Review 1.  Liver resection for cancer.

Authors:  R W Parks; O J Garden
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period.

Authors:  H Lang; K T Nussbaum; P Kaudel; N Frühauf; P Flemming; R Raab
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

3.  Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.

Authors:  Jürgen Weitz; Leslie H Blumgart; Yuman Fong; William R Jarnagin; Michael D'Angelica; Lawrence E Harrison; Ronald P DeMatteo
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

4.  Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes.

Authors:  E Berber; E Ari; N Herceg; A Siperstein
Journal:  Surg Endosc       Date:  2005-10-24       Impact factor: 4.584

5.  Results of hepatic resection for sarcoma metastatic to liver.

Authors:  R P DeMatteo; A Shah; Y Fong; W R Jarnagin; L H Blumgart; M F Brennan
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

6.  Isolated liver perfusion using percutaneous methods: an experimental study in the pig.

Authors:  J Harnek; W Cwikiel; L Bergqvist; B Persson; H Stridbeck
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

7.  The impact of 18F-FDG PET/CT in patients with liver metastases.

Authors:  Siew C Chua; Ashley M Groves; Irfan Kayani; Leon Menezes; Svetislav Gacinovic; Yong Du; Jamshed B Bomanji; Peter J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-23       Impact factor: 9.236

8.  Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer.

Authors:  Kentaro Ueda; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Teiji Naka; Koichiro Ishida; Toshiyasu Ojima; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2008-03-15       Impact factor: 3.445

9.  The role of liver resections for metastases from lung carcinoma.

Authors:  Giorgio Ercolani; Matteo Ravaioli; Gian Luca Grazi; Matteo Cescon; Giovanni Varotti; Massimo Del Gaudio; Gaetano Vetrone; Matteo Zanello; Alfonso Principe; Antonio Daniele Pinna
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 10.  Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies.

Authors:  Luca Martella; Serena Bertozzi; Ambrogio P Londero; Agostino Steffan; Paolo De Paoli; Giulio Bertola
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.